Taking a low-dose aspirin once a day does not reduce the risk of dementia, MCI, nor does it slow the rate of cognitive decline in elderly people, according to findings from a major Australian-led trial. Published in Neurology the results of the Aspirin in Reducing Events in the Elderly (ASPREE) randomised controlled trial found no ...
Low dose aspirin does not prevent dementia or cognitive decline: ASPREE trial
By Michael Woodhead
1 Apr 2020